Answers are grounded in this paper and cite their sources.
We retrospectively assessed the renal toxicity associated with the use of intravenous colistin. Fifty-four patients with multidrug-resistant Acinetobacter infections were included. At the end of therapy 6/54 patients (11%) suffered renal impairment. Renal impairment associated with the use of colistin is less frequent than initially reported.
No takes yet. Share an insight, caveat, or question.
Santamaría et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: